
Inside Health Potential Break Through in Dementia Treatment
Aug 26, 2025
Dr. Pascal Geldsetzer, Assistant Professor at Stanford University, reveals groundbreaking research linking the shingles vaccine to a 20% reduced risk of developing dementia. He discusses the implications of viral infections on brain health and the need for further studies. The conversation also touches upon a new gonorrhea vaccine targeting antibiotic resistance, and innovative robotic clothing designed to assist elderly mobility. These advancements may revolutionize healthcare strategies and independence for aging populations.
AI Snips
Chapters
Transcript
Episode notes
Why Gonorrhoea Rates Are Rising
- Gonorrhoea cases are rising due to more partners, changing behaviour, and increased testing.
- Suneeta Soni emphasizes behaviour shifts and testing both drive observed increases.
Gonorrhoea Nears Last-Line Antibiotics
- Gonorrhoea has evolved resistance to many antibiotics and ceftriaxone is the current last-line injection.
- Suneeta Soni warns that resistance is increasing and treatment options are dwindling.
Why Gonorrhoea Becomes Drug-Resistant
- Neisseria gonorrhoeae uses multiple mechanisms to resist drugs and can acquire genes from other bacteria.
- This genetic adaptability makes it more prone to multi-drug resistance than chlamydia.
